Australian Evidence-Based Clinical Guidelines for Diabetes

Published by Living Evidence for Diabetes Consortium on Nov 27, 2020

Disclaimer

These clinical guidelines are a general guide to appropriate practice, to be followed subject to the clinician’s judgement and the patient’s preference in each individual case. The guidelines are not intended to be prescriptive. They are designed to provide information to assist decision making and have been informed by the highest quality evidence available at the time of compilation. Accordingly, the parties involved in the development of these guidelines shall have no liability to any users of the information contained in this publication for any loss or damage, cost or expense incurred or arising from reliance on the information contained in this publication.   
 

Sponsors

Funding and in-kind support for the development of these clinical guidelines was provided by the Australian Government Department of Health, Monash University Division of Metabolism, Ageing and Genomics, Australian Diabetes Society, Australian Diabetes Educators Association, Diabetes Australia, Australian Paediatric Endocrine Group and Cochrane Australia.
 
 

Contact

Abstract

Language

en

PICOS

PICO 1.1

Population
Adults with type 1 diabetes
Intervention
CGM with alerts + MDI
Comparator
SMBG + MDI
Outcomes

PICO 1.1

Population
Adults with type 2 diabetes
Intervention
Therapeutics for blood glucose control
Comparator
Metformin or standard care
Outcomes

PICO 1.2

Population
Adults with type 1 diabetes
Intervention
CGM without alerts + MDI
Comparator
SMBG+MDI
Outcomes

PICO 1.3

Population
Adults with type 1 diabetes
Intervention
Flash + MDI
Comparator
SMBG + MDI
Outcomes

PICO 2.1

Population
Children with type 1 diabetes
Intervention
CSII
Comparator
MDI
Outcomes

PICO 2.2

Population
Adults with type 1 diabetes
Intervention
Insulin pump (CSII)
Comparator
Multiple daily injections (MDI)
Outcomes

PICO 2.3

Population
NEW Adults with type 1 diabetes
Intervention
Insulin pump (CSII)
Comparator
Multiple daily injections (MDI)
Outcomes

PICO 3.1

Population
Children, adolescents and adults with type 1 diabetes
Intervention
AutoCSII
Comparator
CSII
Outcomes

PICO 3.2

Population
NEW Children, adolescents and adults with type 1 diabetes
Intervention
AutoCSII
Comparator
CSII
Outcomes